Results 131 to 140 of about 6,339 (219)

Antipsychotic drugs at 75: the past, present, and future of psychosis management. [PDF]

Br Med Bull
Lyman M, McCutcheon RA.
europepmc   +1 more source

Correction to: From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials. [PDF]

Int J Neuropsychopharmacol
europepmc   +1 more source

The Central Cholinergic Synapse: A Primer. [PDF]

Int J Mol Sci
Klein J.
europepmc   +1 more source

Pharmacological and light-driven pupillary accommodation in guinea pigs: comparative effects of muscarinic modulators and illumination across developmental stages. [PDF]

Int J Ophthalmol
Wu H, Lu N, Qiao ZB, Cheng C, Luo WT, Wan T, Qiao T, Di Y.   +7 more
europepmc   +1 more source

Investigation of the presence and antinociceptive function of muscarinic acetylcholine receptors in the African naked mole-rat () [PDF]

core   +1 more source

Neuroplasticity and neuroimmune interactions with type 2 inflammation in asthma. [PDF]

Eur Respir Rev
Koster CS, Lavitola C, Teodorescu R, Bakker BA, Gosens R.   +4 more
europepmc   +1 more source

Dynamic cholinergic signaling differentially desynchronizes cortical microcircuits dependent on modulation rate and network connectivity. [PDF]

PLoS Comput Biol
Pandian S, Rich S.
europepmc   +1 more source

Design, Synthesis, and Evaluation of a New Fluorescent Ligand for the M₂ Muscarinic Acetylcholine Receptor. [PDF]

ACS Med Chem Lett
Szabó R, Szepesi Kovács D, Kiss DJ, Yazdi ZN, Tóth AD, Brea J, Loza MI, Meszéna D, Wittner L, Ulbert I, Volk B, Hunyady L, Keserű GM.   +12 more
europepmc   +1 more source

Targeting muscarinic receptors for treating schizophrenia. [PDF]

Neurotherapeutics
Paul SM, Yohn SE.
europepmc   +1 more source